Bioactive glasses for wound healing

Bioactive Glasses: Materials, Properties and Applications

Volumn , Issue , 2011, Pages 246-266

  Mohammadi, M Shah ^a   Stahli C ^a   Nazhat, S N ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Angiogenesis; Antimicrobial; Phosphate based glass; Silicate based glass; Wound healing

Indexed keywords

EID: 84868461768     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-84569-768-6.50012-0     Document Type: Chapter

References (97)

1. 2O). Journal of Biomedical Materials Research Part A 2003, 66A(1):110-119.
2. Gough J.E., Notingher I., Hench L.L. Osteoblast attachment and mineralized nodule formation on rough and smooth 45S5 bioactive glass monoliths. Journal of Biomedical Materials Research Part A 2004, 68A(4):640-650.
3. Day R.M., Boccaccini A.R. Effect of particulate bioactive glasses on human macrophages and monocytes in vitro. Journal of Biomedical Materials Research Part A 2005, 73A(1):73-79.
4. Gough J.E., Jones J.R., Hench L.L. Nodule formation and mineralisation of human primary osteoblasts cultured on a porous bioactive glass scaffold. Biomaterials 2004, 25(11):2039-2046.
5. Hench L.L., West J.K. Biological applications of bioactive glasses. Life Chemistry Reports 1996, 13:187.
6. Hench L.L., Wilson J. An Introduction to Bioceramics 1993, World Scientific. 2nd ed.
7. Delahaye F., Montagne L., Palavit G., Touray J.C., Baillif P. Acid dissolution of sodium-calcium metaphosphate glasses. Journal of Non-Crystalline Solids 1998, 242(1):25-32.
8. Patel A., Knowles J.C. Investigation of silica-iron-phosphate glasses for tissue engineering. Journal of Materials Science: Materials in Medicine 2006, 17(10):937-944.
9. Gao H., Tan T., Wang D. Effect of composition on the release kinetics of phosphate controlled release glasses in aqueous medium. Journal of Controlled Release 2004, 96(1):21-28.
10. Franks K., Abrahams I., Knowles J.C. Development of soluble glasses for biomedical use Part I: In vitro solubility measurement. Journal of Materials Science: Materials in Medicine 2000, 11(10):609-614.
11. Abou Neel E.A., Knowles J.C. Physical and biocompatibility studies of novel titanium dioxide doped phosphate-based glasses for bone tissue engineering applications. Journal of Materials Science: Materials in Medicine 2008, 19(1):377-386.
12. Ahmed I., Parsons A.J., Rudd C.D., Nazhat S.N., Knowles J.C., Guerry P., Smith M.E. Comparison of phosphate-based glasses in the range 50P(2)O(5)-(50-x) CaO-xNa(2)O prepared using different precursors. Glass Technology-European Journal of Glass Science and Technology Part A 2008, 49(2):63-72.
13. 2O glass system. Biomaterials 2004, 25(3):491-499.
14. 2O5-CaO-NajO glass fibre system. Biomaterials 2004, 25(3):501-507.
15. Gough J.E., Christian P., Scotchford C.A., Rudd C.D., Jones I.A. Synthesis, degradation, and in vitro cell responses of sodium phosphate glasses for craniofacial bone repair. Journal of Biomedical Materials Research 2002, 59(3):481-489.
16. Gough J.E., Christian P., Scotchford C.A., Jones I.A. Long-term craniofacial osteoblast culture on a sodium phosphate and a calcium/sodium phosphate glass. Journal of Biomedical Materials Research - Part A 2003, 66(2):233-240.
17. Abou Neel E.A., Pickup D.M., Valappil S.P., Newport R.J., Knowles J.C. Bioactive functional materials: A perspective on phosphate-based glasses. Journal of Materials Chemistry 2009, 19(6):690-701.
18. Hoppe U. A structural model for phosphate glasses. Journal of Non-Crystalline Solids 1996, 195(1-2):138-147.
19. Kirkpatrick R.J., Brow R.K. Nuclear magnetic resonance investigation of the structures of phosphate and phosphate-containing glasses: a review. Solid State Nuclear Magnetic Resonance 1995, 5(1):9-21.
20. Sales B.C., Boatner L.A., Ramey J.O. Chromatographic studies of the structures of amorphous phosphates: a review. Journal of Non-Crystalline Solids 2000, 263:155-166.
21. Bunker B.C., Arnold G.W., Wilder J.A. Phosphate glass dissolution in aqueous solutions. Journal of Non-Crystalline Solids 1984, 64(3):291-316.
22. Bae B.S., Weinberg M.C. Oxidation-reduction equilibrium in copper phosphate-glass melted in air. Journal of the American Ceramic Society 1991, 74(12):3039-3045.
23. Salih V., Franks K., James M., Hastings G.W., Knowles J.C., Olsen I. Development of soluble glasses for biomedical use part II: The biological response of human osteoblast cell lines to phosphate-based soluble glasses. Journal of Materials Science: Materials in Medicine 2000, 11(10):615-620.
24. Abou Neel E.A., Ahmed I., Blaker J.J., Bismarck A., Boccaccini A.R., Lewis M.P., Nazhat S.N., Knowles J.C. Effect of iron on the surface, degradation and ion release properties of phosphate-based glass fibres. Acta Biomaterialia 2005, 1(5):553-563.
25. Franks K., Salih V., Knowles J.C., Olsen I. The effect of MgO on the solubility behavior and cell proliferation in a quaternary soluble phosphate based glass system. Journal of Materials Science: Materials in Medicine 2002, 13(6):549-556.
26. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: A common cause of persistent infections. Science 1999, 284(5418):1318-1322.
27. Drenkard E., Ausubel F.M. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 2002, 416(6882):740-743.
28. Donlan R.M., Costerton J.W. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clinical Microbiology Reviews 2002, 15(2):167-193.
29. Shirtliff M.E., Mader J.T., Camper A.K. Molecular interactions in biofilms. Chemistry & Biology 2002, 9(8):859-871.
30. Sauer K., Camper A.K., Ehrlich G.D., Costerton J.W., Davies D.G. Pseudomonas aeruginosa displays multiple phenotypes during development as a 31. biofilm. Journal of Bacteriology 2002, 184(4):1140-1154.
31. Ceri H., Olson M.E., Stremick C., Read R.R., Morck D., Buret A. The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. Journal of Clinical Microbiology 1999, 37(6):1771-1776.
32. Oie S., Huang Y., Kamiya A., Konishi H., Nakazawa T. Efficacy of disinfectants against biofilm cells of methicillin-resistant Staphylococcus aureus. Microbios 1996, 85(345):223-230.
33. Shiau A.L., Wu C.L. The inhibitory effect of Staphylococcus epidermidis slime on the phagocytosis of murine peritoneal macrophages is interferon-independent. Microbiology and Immunology 1998, 42(1):33-40.
34. Kaneko Y., Thoendel M., Olakanmi O., Britigan B.E., Singh P.K. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. Journal of Clinical Investigation 2007, 117(4):877-888.
35. Valappil S.P., Ready D., Abou Neel E.A., Pickup D.M., Chrzanowski W., O'Dell L.A., Newport R.J., Smith M.E., Wilson M., Knowles J.C. Antimicrobial gallium-doped phosphate-based glasses. Advanced Functional Materials 2008, 18(5):732-741.
36. Valappil S.P., Ready D., Abou Neel E.A., Pickup D.M., O'Dell L.A., Chrzanowski W., Pratten J., Newport R.J., Smith M.E., Wilson M., Knowles J.C. Controlled delivery of antimicrobial gallium ions from phosphate-based glasses. Acta Biomaterialia 2009, 5(4):1198-1210.
37. Cartmell S.H., Doherty P.J., Rhodes N.P., Hunt J.A., Healy D.M., Gilchrist T. Haemocompatiblity of controlled release glass. Journal of Materials Science: Materials in Medicine 1998, 9(1):1-7.
38. Lansdown A.B.G. Silver. I: Its antibacterial properties and mechanism of action. J Wound Care 2002, 11(4):125-130.
39. Lansdown A.B.G. Silver. 2: Toxicity in mammals and how its products aid wound repair. J Wound Care 2002, 11(5):173-177.
40. Lansdown A.B.G., Sampson B., Laupattarakasem P., Vuttivirojana A. Silver aids healing in the sterile skin wound: experimental studies in the laboratory rat. British Journal of Dermatology 1997, 137(5):728-735.
41. Bellantone M., Coleman N.J., Hench L.L. Bacteriostatic action of a novel four-component bioactive glass. Journal of Biomedical Materials Research 2000, 51(3):484-490.
42. Clupper D.C., Hench L.L. Bioactive response of Ag-doped tape cast Bioglass® 45S5 following heat treatment. Journal of Materials Science: Materials in Medicine 2001, 12(10-12):917-921.
43. 2O-doped bioactive glass. Antimicrobial Agents and Chemotherapy 2002, 46(6):1940-19245.
44. Stamboulis A., Hench L.L., Boccaccini A.R. Mechanical properties of biodegradable polymer sutures coated with bioactive glass. Journal of Materials Science: Materials in Medicine 2002, 13(9):843-848.
45. Stamboulis A.G., Boccaccini A.R., Hench L.L. Novel biodegradable polymer/bioactive glass composites for tissue engineering applications. Advanced Engineering Materials 2002, 4(3):105-109.
46. Boccaccini A.R., Stamboulis A.G., Rashid A., Roether J.A. Composite surgical sutures with bioactive glass coating. Journal of Biomedical Materials Research Part B-Applied Biomaterials 2003, 67B(1):618-626.
47. Stamboulis A., Hench L.L. Bioresorbable polymers: Their potential as scaffolds for Bioglass® composites. Bioceramics 2000, 192(1):729-732.
48. Blaker J.J., Nazhat S.N., Boccaccini A.R. Development and characterisation of silver-doped bioactive glass coated sutures for tissue engineering and wound healing applications. Biomaterials 2004, 25(7-8):1319-1329.
49. Pratten J., Nazhat S.N., Blaker J.J., Boccaccini A.R. In vitro attachment of Staphylococcus epidermidis to surgical sutures with and without Ag-containing bioactive glass coating. Journal of Biomaterials Applications 2004, 19(1):47-57.
50. Ahmed I., Abou Neel E.A., Valappil S.P., Nazhat S.N., Pickup D.M., Carta D., Carroll D.L., Newport R.J., Smith M.E., Knowles J.C. The structure and properties of silver-doped phosphate-based glasses. Journal of Materials Science 2007, 42:9827-9835.
51. Ahmed I., Ready D., Wilson M., Knowles J.C. Antimicrobial effect of silver-doped phosphate-based glasses. Journal of Biomedical Materials Research Part A 2006, 79(3):618-626.
52. Valappil S.P., Pickup D.M., Carroll D.L., Hope C.K., Pratten J., Newport R.J., Smith M.E., Wilson M., Knowles J.C. Effect of silver content on the structure and antibacterial activity of silver-doped phosphate-based glasses. Antimicrobial Agents and Chemotherapy 2007, 51(12):4453-4461.
53. Valappil S.P., Knowles J.C., Wilson M. Effect of silver-doped phosphate-based glasses on bacterial biofilm growth. Applied and Environmental Microbiology 2008, 74(16):5228-5230.
54. Saravanapavan P., Gough J.E., Jones J.R., Hench L.L. Antimicrobial macroporous gel-glasses: dissolution and cytotoxicity. Key Engineering Materials 2004, 254-256:1087-1090.
55. Gould S.W.J., Fielder M.D., Kelly A.F., Morgan M., Kenny J., Naughton D.P. The antimicrobial properties of copper surfaces against a range of important nosocomial pathogens. Annals of Microbiology 2009, 59(1):151-156.
56. Perelshtein I., Applerot G., Perkas N., Wehrschuetz-Sigl E., Hasmann A., Guebitz G., Gedanken A. CuO-cotton nanocomposite: Formation, morphology, and antibacterial activity. Surface & Coatings Technology 2009, 204(1-2):54-57.
57. Mulligan A.M., Wilson M., Knowles J.C. The effect of increasing copper content in phosphate-based glasses on biofilms of Streptococcus sanguis. Biomaterials 2003, 24(10):1797-1807.
58. Abou Neel A.E., Ahmed I., Pratten J., Nazhat S.N., Knowles J.C. Characterisation of antibacterial copper releasing degradable phosphate glass fibres. Biomaterials 2005, 26(15):2247-2254.
59. Stoor P., Söderling E., Salonen J.I. Antibacterial effect of a bioactive glass paste on oral microorganisms. Acta Odontologica Scandinavica 1998, 56(3):161-165.
60. Stoor P., Söderling E., Grénman R. Bioactive glass S53P4 in repair of septal perforations and its interactions with the respiratory infection-associated microorganisms Heamophilus influenzae and Streptococcus pneumoniae. Journal of Biomedical Materials Research Part A 2000, 58(1):113-120.
61. Stoor P., Söderling E., Grénman R. Interactions between the bioactive glass S53P4 and atrophic rhinitis-associated microorganism Klebsiella ozaenae. Journal of Biomedical Materials Research Part A 2000, 48(6):869-874.
62. Gorustovich A., Roether J., Boccaccini A.R. Effect of bioactive glasses on angiogenesis: In vitro and in vivo evidence. A review. Tissue Engineering Part B 2009, 16(2):199-207.
63. Day R.M. Bioactive glass stimulates the secretion of angiogenic growth factors and angiogenesis in vitro. Tissue Engineering 2005, 11(5-6):768-777.
64. Keshaw H., Forbes A., Day R.M. Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass. Biomaterials 2005, 26(19):4171-4179.
65. Day R.M., Maquet V., Boccaccini A.R., Jérôme R., Forbes A. In vitro and in vivo analysis of macroporous biodegradable poly(D, L-lactide-co-glycolide) scaffolds containing bioactive glass. Journal of Biomedical Materials Research Part A 2005, 75A(4):778-787.
66. Keshaw H., Georgiou G., Blaker J.J., Forbes A., Knowles J.C., Day R.M. Assessment of polymer/bioactive glass-composite microporous spheres for tissue regeneration applications. Tissue Engineering Part A 2009, 15(7):1451-1461.
67. Leach J.K., Kaigler D., Wang Z., Krebsbach P.H., Mooney D.J. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials 2006, 27(17):3249-3255.
68. Leu A., Leach J.K. Proangiogenic potential of a collagen/bioactive glass substrate. Pharmaceutical Research 2008, 25(5):1222-1229.
69. Leu A., Stieger S.M., Dayton P., Ferrara K.W., Leach J.K. Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect. Tissue Engineering Part A 2009, 15(4):877-885.
70. Vargas G.E., Mesones R.V., Bretcanu O., López J.M.P., Boccaccini A.R., Gorustovich A. Biocompatibility and bone mineralization potential of 45S5 Bioglass®-derived glass-ceramic scaffolds in chick embryos. Acta Biomaterialia 2009, 5(1):374-380.
71. Andrade A.L., Andrade S.P., Domingues R.Z. In vivo performance of a sol-gel glass-coated collagen. Journal of Biomedical Materials Research Part B - Applied Biomaterials 2006, 79B(1):122-128.
72. Tommila M., Jokinen J., Wilson T., Forsback A.P., Saukko P., Penttinen R., Ekholm E. Bioactive glass-derived hydroxyapatite-coating promotes granulation tissue growth in subcutaneous cellulose implants in rats. Acta Biomaterialia 2008, 4(2):354-361.
73. Renvall S., Lehto M., Penttinen R. Development of peritoneal fibrosis occurs under the mesothelial cell layer. Journal of Surgical Research 1987, 43(5):407-412.
74. Aina V., Malavasi G., Pla A.F., Munaron L., Morterra C. Zinc-containing 74. bioactive glasses: Surface reactivity and behaviour towards endothelial cells. Acta Biomaterialia 2009, 5(4):1211-1222.
75. Jaervelaeinen H., Laato M., Salonen J., Vedel E. and Jarvelainen H., 'Bioactive glass composition useful for treating lesions associated with compromised or poor vascularisation comprises silica, sodium oxide, calcium oxide, potassium oxide, magnesium oxide, boric anhydride and phosphorus pentoxide', VIVOXID OY (VIVO-Non-standard), 1831119-A1.
76. Chen Y., Shi G., Ding Y., Yu X., Zhang X., Zhao C., Wan C. In vitro study on the influence of strontium-doped calcium polyphosphate on the angiogenesis-related behaviors of HUVECs. Journal of Materials Science: Materials in Medicine 2008, 19(7):2655-2662.
77. Lao J., Nedelec J.M., Jallot E. New strontium-based bioactive glasses: physicochemical reactivity and delivering capability of biologically active dissolution products. Journal of Materials Chemistry 2009, 19(19):2940-2949.
78. Gorustovich A.A., Steimetz T., Cabrini R.L., Lopez J.M.P. Osteoconductivity of strontium-doped bioactive glass particles: A histomorphometric study in rats. Journal of Biomedical Materials Research Part A 2010, 92A(1):232-237.
79. McAuslan B.R., Reilly W. Endothelial-cell phagokinesis in response to specific metal-ions. Experimental Cell Research 1980, 130(1):147-157.
80. Parke A., Bhattacherjee P., Palmer R.M.J., Lazarus N.R. Characterization and quantification of copper sulfate-induced vascularization of the rabbit cornea. American Journal of Pathology 1988, 130(1):173-178.
81. Hu G.F. Copper stimulates proliferation of human endothelial cells under culture. Journal of Cellular Biochemistry 1998, 69(3):326-335.
82. Sen C.K., Khanna S., Venojarvi M., Trikha P., Ellison E.C., Hunt T.K., Roy S. Copper-induced vascular endothelial growth factor expression and wound healing. American Journal of Physiology-Heart and Circulatory Physiology 2002, 282(5):H1821-H1827.
83. Frangoulis M., Georgiou P., Chrisostomidis C., Perrea D., Dontas I., Kavantzas N., Kostakis A., Papadopoulos O. Rat epigastric flap survival and VEGF expression after local copper application. Plastic and Reconstructive Surgery 2007, 119(3):837-843.
84. Borkow G., Gabbay J., Dardik R., Eidelman A.I., Lavie Y., Grunfeld Y., Ikher S., Huszar M., Zatcoff R.C., Marikovsky M. Molecular mechanisms of enhanced wound healing by copper oxide-impregnated dressings. Wound Repair and Regeneration 2010, 18(2):266-275.
85. Barralet J., Gbureck U., Habibovic P., Vorndran E., Gerard C., Doillon C.J. Angiogenesis in Calcium Phosphate Scaffolds by Inorganic Copper Ion Release. Tissue Engineering Part A 2009, 15(7):1601-1609.
86. Gérard C., Bordeleau L.J., Barralet J., Doillon C.J. The stimulation of angiogenesis and collagen deposition by copper. Biomaterials 2009, 31(5):824-831.
87. Barbucci R., Lamponi S., Magnani A., Peluso G., Petillo O. Metal complexes with linear and crosslinked polysaccharides as mediators of angiogenesis. Polymers for Advanced Technologies 2001, 12(3-4):271-278.
88. Giavaresi G., Torricelli P., Fornasari P.M., Giardino R., Barbucci R., Leone G. Blood vessel formation after soft-tissue implantation of hyaluronan based hydrogel supplemented with copper ions. Biomaterials 2005, 26(16):3001-3008.
89. Goodman V.L., Brewer G.J., Merajver S.D. Copper deficiency as an anti-cancer strategy. Endocrine-Related Cancer 2004, 11(2):255-263.
90. Feng W., Ye F., Xue W., Zhou Z., Kang Y.J. Copper regulation of hypoxia-inducible factor-1 activity. Molecular Pharmacology 2009, 75(1):174-182.
91. Bar-Or D., Thomas G.W., Yukl R.L., Rael L.T., Shimonkevitz R.P., Curtis C.G., Winkler J.V. Copper stimulates the synthesis and release of interleukin-8 in human endothelial cells: a possible early role in systemic inflammatory responses. Shock 2003, 20(2):154-158.
92. Kobayashi H., Ishii M., Chanoki M., Yashiro N., Fushida H., Fukai K., Kono T., Hamada T., Wakasaki H., Ooshima A. Immunohistochemical localization of lysyl oxidase in normal human skin. British Journal of Dermatology 1994, 131(3):325-330.
93. Tahery M.M., Lee D.A. Pharmacologic control of wound-healing in glaucoma filtration surgery - review. Journal of Ocular Pharmacology 1989, 5(2):155-179.
94. Azevedo M., Hill R. G., Jell G. and Stevens M. M., 'Glass, e.g. for use in bone or hard tissue applications and soft tissue applications, comprises silica, phosphorus pentoxide, calcium oxide and strontium oxide, sodium oxide and potassium oxide, and source of hypoxia mimicking ions', Imperial Innovations Ltd., 62.
95. Malda J., Klein T.J., Upton Z. The roles of hypoxia in the in vitro engineering of tissues. Tissue Engineering 2007, 13:2153-2162.
96. Azevedo M. Hypoxia-mimicking materials for bone and cartilage tissue engineering. European Cells and Materials 2009, 18(Suppl. 2):45.
97. Azevedo M., Jell G., Hill R., Stevens M.M. Novel hypoxia mimicking bioactive materials for tissue engineering. Tissue Engineering Part A 2008, 14(5):889.